Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Comparative Proteomics of Activated THP-1 Cells Infected with Mycobacterium tuberculosis Identifies Putative Clearance Biomarkers for Tuberculosis Treatment.

Kaewseekhao B, Naranbhai V, Roytrakul S, Namwat W, Paemanee A, Lulitanond V, Chaiprasert A, Faksri K.

PLoS One. 2015 Jul 27;10(7):e0134168. doi: 10.1371/journal.pone.0134168. eCollection 2015.

2.

Proteomics of Mycobacterium Infection: Moving towards a Better Understanding of Pathogen-Driven Immunomodulation.

Hoffmann E, Machelart A, Song OR, Brodin P.

Front Immunol. 2018 Jan 30;9:86. doi: 10.3389/fimmu.2018.00086. eCollection 2018. Review.

3.

Identification of Host Proteins Predictive of Early Stage Mycobacterium tuberculosis Infection.

Bark CM, Manceur AM, Malone LL, Nsereko M, Okware B, Mayanja HK, Joloba ML, Rajotte I, Mentinova M, Kay P, Lo S, Tremblay P, Stein CM, Boom WH, Paramithiotis E.

EBioMedicine. 2017 Jul;21:150-157. doi: 10.1016/j.ebiom.2017.06.019. Epub 2017 Jun 20.

4.

Comparison of the membrane proteome of virulent Mycobacterium tuberculosis and the attenuated Mycobacterium bovis BCG vaccine strain by label-free quantitative proteomics.

Gunawardena HP, Feltcher ME, Wrobel JA, Gu S, Braunstein M, Chen X.

J Proteome Res. 2013 Dec 6;12(12):5463-74. doi: 10.1021/pr400334k. Epub 2013 Oct 28.

5.

Changes in the Membrane-Associated Proteins of Exosomes Released from Human Macrophages after Mycobacterium tuberculosis Infection.

Diaz G, Wolfe LM, Kruh-Garcia NA, Dobos KM.

Sci Rep. 2016 Nov 29;6:37975. doi: 10.1038/srep37975.

6.

Differential expression of NF-kappaB in mycobacteria infected THP-1 affects apoptosis.

Dhiman R, Raje M, Majumdar S.

Biochim Biophys Acta. 2007 Apr;1770(4):649-58. Epub 2006 Dec 6.

PMID:
17204371
7.

Some proteins of M. tuberculosis that localise to the nucleus of THP-1-derived macrophages.

Agrawal AK, Ranjan R, Chandra S, Rout TK, Misra A, Reddy TJ.

Tuberculosis (Edinb). 2016 Dec;101:75-78. doi: 10.1016/j.tube.2016.07.013. Epub 2016 Jul 30.

PMID:
27865402
8.

Portrait of a pathogen: the Mycobacterium tuberculosis proteome in vivo.

Kruh NA, Troudt J, Izzo A, Prenni J, Dobos KM.

PLoS One. 2010 Nov 11;5(11):e13938. doi: 10.1371/journal.pone.0013938.

9.

IL-10 blocks phagosome maturation in mycobacterium tuberculosis-infected human macrophages.

O'Leary S, O'Sullivan MP, Keane J.

Am J Respir Cell Mol Biol. 2011 Jul;45(1):172-80. doi: 10.1165/rcmb.2010-0319OC. Epub 2010 Oct 1.

PMID:
20889800
10.

Host targeted activity of pyrazinamide in Mycobacterium tuberculosis infection.

Manca C, Koo MS, Peixoto B, Fallows D, Kaplan G, Subbian S.

PLoS One. 2013 Aug 28;8(8):e74082. doi: 10.1371/journal.pone.0074082. eCollection 2013.

11.

Flavonoid Mixture Inhibits Mycobacterium tuberculosis Survival and Infectivity.

Cao R, Teskey G, Islamoglu H, Gutierrez M, Salaiz O, Munjal S, Fraix MP, Sathananthan A, Nieman DC, Venketaraman V.

Molecules. 2019 Feb 28;24(5). pii: E851. doi: 10.3390/molecules24050851.

12.

Phosphodiesterase 4 inhibition reduces innate immunity and improves isoniazid clearance of Mycobacterium tuberculosis in the lungs of infected mice.

Koo MS, Manca C, Yang G, O'Brien P, Sung N, Tsenova L, Subbian S, Fallows D, Muller G, Ehrt S, Kaplan G.

PLoS One. 2011 Feb 25;6(2):e17091. doi: 10.1371/journal.pone.0017091.

13.

Detection of Mycobacterium tuberculosis peptides in the exosomes of patients with active and latent M. tuberculosis infection using MRM-MS.

Kruh-Garcia NA, Wolfe LM, Chaisson LH, Worodria WO, Nahid P, Schorey JS, Davis JL, Dobos KM.

PLoS One. 2014 Jul 31;9(7):e103811. doi: 10.1371/journal.pone.0103811. eCollection 2014.

14.

Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response.

Adekambi T, Ibegbu CC, Cagle S, Kalokhe AS, Wang YF, Hu Y, Day CL, Ray SM, Rengarajan J.

J Clin Invest. 2015 May;125(5):1827-38. doi: 10.1172/JCI77990. Epub 2015 Mar 30. Erratum in: J Clin Invest. 2015 Sep;125(9):3723.

16.

The stress-response factor SigH modulates the interaction between Mycobacterium tuberculosis and host phagocytes.

Dutta NK, Mehra S, Martinez AN, Alvarez X, Renner NA, Morici LA, Pahar B, Maclean AG, Lackner AA, Kaushal D.

PLoS One. 2012;7(1):e28958. doi: 10.1371/journal.pone.0028958. Epub 2012 Jan 3.

17.

Mycobacterium tuberculosis serine protease Rv3668c can manipulate the host-pathogen interaction via Erk-NF-╬║B axis-mediated cytokine differential expression.

Zhao Q, Li W, Chen T, He Y, Deng W, Luo H, Xie J.

J Interferon Cytokine Res. 2014 Sep;34(9):686-98. doi: 10.1089/jir.2013.0071. Epub 2014 Mar 31.

18.

Caspase-3-independent apoptotic pathways contribute to interleukin-32╬│-mediated control of Mycobacterium tuberculosis infection in THP-1 cells.

Bai X, Kinney WH, Su WL, Bai A, Ovrutsky AR, Honda JR, Netea MG, Henao-Tamayo M, Ordway DJ, Dinarello CA, Chan ED.

BMC Microbiol. 2015 Feb 21;15:39. doi: 10.1186/s12866-015-0366-z.

19.

The glycosylated Rv1860 protein of Mycobacterium tuberculosis inhibits dendritic cell mediated TH1 and TH17 polarization of T cells and abrogates protective immunity conferred by BCG.

Satchidanandam V, Kumar N, Jumani RS, Challu V, Elangovan S, Khan NA.

PLoS Pathog. 2014 Jun 12;10(6):e1004176. doi: 10.1371/journal.ppat.1004176. eCollection 2014 Jun. Erratum in: PLoS Pathog. 2014 Aug;10(8):e1004352.

20.

Networked T cell death following macrophage infection by Mycobacterium tuberculosis.

Macdonald SH, Woodward E, Coleman MM, Dorris ER, Nadarajan P, Chew WM, McLaughlin AM, Keane J.

PLoS One. 2012;7(6):e38488. doi: 10.1371/journal.pone.0038488. Epub 2012 Jun 4.

Supplemental Content

Support Center